PFE · Pfizer Inc
$26.79
-0.01 (-0.04%)
At close · Aug 14
Market Cap
$152.69B
Shares
5.70B
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-08-04 | 2026-06-28 | |
| 8-K | 2026-08-04 | — | |
| 8-K | 2026-06-18 | — | |
| 8-K | 2026-06-18 | — | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-05 | — | |
| 10-Q | 2026-05-05 | 2026-03-29 | |
| 8-K | 2026-04-27 | 2026-04-23 | |
| DEF 14A | 2026-03-12 | 2026-04-23 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-03 | — | |
| 8-K | 2025-12-16 | — | |
| 8-K | 2025-11-21 | 2025-11-18 | |
| 8-K | 2025-11-13 | — | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-28 | |
| 10-Q | 2025-08-05 | 2025-06-29 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-05-19 | 2025-05-14 | |
| 10-Q | 2025-05-05 | 2025-03-30 | |
| 8-K | 2025-04-29 | — | |
| 8-K | 2025-04-28 | 2025-04-24 | |
| DEF 14A | 2025-03-13 | 2025-04-24 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-04 | — | |
| 8-K | 2024-12-17 | — | |
| 10-Q | 2024-11-04 | 2024-09-29 | |
| 8-K | 2024-10-29 | — | |
| 8-K | 2024-10-15 | 2024-10-10 | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-07-30 | — | |
| 8-K | 2024-07-26 | 2024-07-24 | |
| 8-K | 2024-07-10 | 2024-07-09 | |
| 8-K | 2024-07-01 | 2024-06-27 | |
| 8-K | 2024-05-22 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-01 | — | |
| 8-K | 2024-04-29 | 2024-04-25 | |
| DEF 14A | 2024-03-14 | 2024-04-25 | |
| 10-K | 2024-02-22 | 2023-12-31 | |
| 8-K | 2024-01-30 | — | |
| 8-K | 2024-01-10 | — | |
| 8-K | 2023-12-14 | — | |
| 8-K/A | 2023-12-14 | — | |
| 8-K | 2023-12-13 | — | |
| 8-K | 2023-12-12 | 2023-12-07 | |
| 10-Q | 2023-11-08 | 2023-10-01 | |
| 8-K | 2023-10-31 | — | |
| 8-K | 2023-10-13 | — |
Showing 1–50 of 122 filings
Key facts
CIK
78003
CUSIP
717081103
13F (30d)
2434 filings
2348 filers
Visit website
Investor relations